Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC

(1) Background: Delay in therapy for pancreatic ductal adenocarcinoma (PDAC) may contribute to a worse outcome. The aim of this study was to investigate the prognostic value of time from diagnosis to surgery in patients undergoing upfront surgery for primarily resectable pancreatic carcinoma. (2) Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsen, Anne, Hobbs, Mirianna, Merkel, Susanne, Mittelstädt, Anke, Czubayko, Franziska, Krautz, Christian, Weber, Georg F., Grützmann, Robert, Brunner, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369379/
https://www.ncbi.nlm.nih.gov/pubmed/35956049
http://dx.doi.org/10.3390/jcm11154433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369379/
https://www.ncbi.nlm.nih.gov/pubmed/35956049
http://dx.doi.org/10.3390/jcm11154433

Ejemplares similares